Alternative Medicine Use in Blood Cancer Patients
Part of Blood & lymphatic, Cancer clinical trials.
This study asks patients with blood cancers (leukemia, lymphoma, or myeloma) about their use of complementary and alternative medicine—things like herbs, acupuncture, or special diets—while they receive hospital treatment. The goal is to understand what patients try and whether these approaches affect their care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute leukemia, lymphoma, or myeloma and are currently hospitalized for treatment
- You are 18 years old or older
- You can read and write in French
- You are covered by French health insurance
- You do not have severe cognitive problems or psychiatric conditions that would prevent you from participating
- You are not in the final, terminal stage of your disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to check how blood cancers respond to immunotherapy. It looks at small blood or bone marrow samples before and during treatment to help doctors choose the best therapy.
This study looks at how T-cells (a type of immune cell) work in people with certain blood cancers (B-cell lymphoma or multiple myeloma) compared to healthy volunteers. The goal is to learn more about the immune system in these cancers, which may help improve future treatments.
This study looks at how blood cancer cells use energy (metabolism) and how that affects the immune system. Researchers hope to find new ways to treat these cancers by understanding cell metabolism better.
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
This trial tests if a special tool can help adults aged 60 and older who are newly visiting a blood cancer or bone marrow transplant clinic understand their options and make decisions that fit their needs.
This study is for people with solid tumors who are about to start chemotherapy or radiation. It looks at how these treatments affect blood cells and may help doctors understand changes in blood health over time.
Hear when a new Hematological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.